
Enanta Pharmaceuticals ENTA
$ 8.1
-3.34%
Quarterly report 2024-Q4
added 02-12-2025
Country |
![]() |
IPO year |
2013 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Jay Luly |
Employees in the company |
141 |
Shares |
21.2 K |
Market Cap[1] |
$ 171 K |
EBITDA (LTM) |
$ -181 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.